Article Sidebar
Views PDF: 28
Outcomes of extracorporeal membrane oxygenation treatment post open congenital heart surgery
Main Article Content
Abstract
Objective: ECMO (Extra-Corporeal Membrane Oxygenation) is a technique that temporarily supports heart and lung function by a cardiopulmonary bypass system to treat patients who have failed to respond to the conventional treatments for cardiac or respiratory after congenital heart surgery. The objective of this study is to evaluate the outcomes of ECMO treatment post congenital heart surgery at the National Children's Hospital.
Subjects and methods: Descriptive, cross-sectional research method on 63 ECMO patients post open heart surgery from January 1, 2017 until August 30, 2023 at the Department of Surgical Cardiovascular Intensive Care, Cardiovascular Center, National Children's Hospital.
Results: Of 63 patients analyzed, the median age of the study group was 1.6 months, 88,9% of patients were children younger than 12 months old; median weight is 3.6 kg. The success rate of ECMO weaning was 55,6%. Overall survival of the cohort was 42,9%. The mean ECMO duration was 5,8 (IQR, 3,7-10,6) days, the mean hospital stay was 31 (IQR, 21-50) days, the mean ICU stay was 19 (IQR, 13-29) days. Mechanical complications during ECMO support include cannula bleeding and circuit thrombus. Acute kidney injury, hypertransaminase, and DIC (disseminated intravascular coagulation) are the most common patient-related complications during ECMO.
Conclusion: ECMO is a viable rescue strategy for cardiac surgery patients with ECMO weaning rate and survival rate were 55,6% and 42,9%, respectively, nearly equivalent to other heart centers.
Article Details
Keywords
EMCO, extracorporeal membrane oxygenation, open cardiac surgery, cardiopulmonary bypass
References
[2] G. Baslaim, J. Bashore, F. Al-Malki, and A. Jamjoom, “Can the outcome of pediatric extracorporeal membrane oxygenation after cardiac surgery be predicted?,” Ann Thorac Cardiovasc Surg, vol. 12, no. 1, pp. 21–27, Feb. 2006.
[3] O. Ghez, H. Feier, F. Ughetto, A. Fraisse, B. Kreitmann, and D. Metras, “Postoperative extracorporeal life support in pediatric cardiac surgery: recent results,” ASAIO J, vol. 51, no. 5, pp. 513–516, Sep. 2005
[4] “Frontiers | Clinical Characteristics and Outcomes of Children With Extracorporeal Membrane Oxygenation in a Developing Country: An 11-Year Single-Center Experience.” Accessed: Apr. 04, 2023.
[5] F. Sperotto, P. Cogo, A. Amigoni, A. Pettenazzo, R. R. Thiagarajan, and A. Polito, “Extracorporeal Membrane Oxygenation Support for Failure to Wean From Cardiopulmonary Bypass After Pediatric Cardiac Surgery: Analysis of Extracorporeal Life Support Organization Registry Data,” Critical Care Explorations, vol. 2, no. 9, p. e0183, Sep. 2020
[6] M. Khorsandi et al., “Extracorporeal membrane oxygenation in pediatric cardiac surgery: A retrospective review of trends and outcomes in Scotland,” Annals of Pediatric Cardiology, vol. 11, no. 1, p. 3, Apr. 2018
[7] S. De Hert and A. Moerman, “Myocardial injury and protection related to cardiopulmonary bypass,” Best Practice & Research Clinical Anaesthesiology, vol. 29, no. 2, pp. 137–149, Jun. 2015
[8] H. Itoh, S. Ichiba, Y. Ujike, S. Kasahara, S. Arai, and S. Sano, “Extracorporeal membrane oxygenation following pediatric cardiac surgery: development and outcomes from a single-center experience,” Perfusion, vol. 27, no. 3, pp. 225–229, May 2012
[9] Y. Wu, T. Zhao, Y. Li, S. Wu, C. Wu, and G. Wei, “Use of Extracorporeal Membrane Oxygenation After Congenital Heart Disease Repair: A Systematic Review and Meta-Analysis,” Frontiers in Cardiovascular Medicine, vol. 7, 2020.